Targeting mitofusin 1-mediated mitochondrial dynamics to suppress neuroinflammation and pyroptosis after traumatic brain injury
Burns & Trauma · 06.01.2026 · 14
DOI: 10.1093/burnst/tkag011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Burns & Trauma, online erschienen am 28.01.2026. Verfasst von Tao Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Xicheng District, Beijing 100053, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tianjin Key Medical Discipline (Neurosurgery) Construction Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Traumatic brain injury (TBI) can cause neuroinflammation and neuronal death. The role of mitochondrial dysfunction in regulating inflammasome activation during TBI remains unclear. This study aims to explore mitochondrial regulation of neuroinflammation and pyroptosis after TBI.
Methods
We used a mouse TBI model and in vitro scratch-injured HT22 cells and primary neurons to examine changes in mitochondrial dynamics and nucleotide-binding oligomerization domain-like receptors family pyrin domain-containing 3 (NLRP3) inflammasome activation. Metformin treatment, mitofusin 1 (Mfn1) knockdown and regulation of the Mfn1 pathway were applied to evaluate the therapeutic effects and mechanisms.
Results
TBI triggered NLRP3 inflammasome activation and neuronal pyroptosis, along with impaired mitochondrial function and oxidative stress. Metformin reduced inflammasome activation, improved mitochondrial homeostasis, and alleviated neuronal injury. These effects were lost when Mfn1 was silenced, highlighting its essential role. Furthermore, we determined that the AMPK pathway modulates these observed effects.
Conclusion
Metformin protects against TBI-induced neuronal damage by restoring Mfn1-dependent mitochondrial dynamics and suppressing inflammasome activation. Mfn1 is a key mediator linking mitochondrial health to neuroinflammatory responses in TBI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Xicheng District, Beijing 100053, China.
- Department of Neurosurgery, Tianjin Neurological Institute, State Key Laboratory of Experimental Hematology, Laboratory of Post-Neuroinjury Neurorepair and Regeneration in Central Nervous System Tianjin and Ministry of…
- Department of Neurosurgery, The People's Hospital of Hong Hua Gang District of Zun Yi, No. 185, Wanli Road, Honghuagang District, Zunyi 563000, Guizhou, China.
ORCID-Profile: Tao Liu, Rongcai Jiang
Förderung
- Tianjin Key Medical Discipline (Neurosurgery) Construction Project
- National Natural Science Foundation of China
Zitieren
APA
Liu, T., Mi, L., Chen, B., Nie, M., Wang, S., Wang, B., Yu, Y., & Jiang, R. (2026). Targeting mitofusin 1-mediated mitochondrial dynamics to suppress neuroinflammation and pyroptosis after traumatic brain injury. Burns & Trauma, 14. https://doi.org/10.1093/burnst/tkag011
Vancouver
Liu T, Mi L, Chen B, Nie M, Wang S, Wang B, et al. Targeting mitofusin 1-mediated mitochondrial dynamics to suppress neuroinflammation and pyroptosis after traumatic brain injury. Burns & Trauma. 2026;14. doi:10.1093/burnst/tkag011
BibTeX
@article{Liu2026,
author = {Liu, Tao and Mi, Liang and Chen, Bo and Nie, Meng and Wang, Shuo and Wang, Bo and Yu, Yunhu and Jiang, Rongcai},
title = {Targeting mitofusin 1-mediated mitochondrial dynamics to suppress neuroinflammation and pyroptosis after traumatic brain injury},
journal = {Burns & Trauma},
year = {2026},
volume = {14},
doi = {10.1093/burnst/tkag011}
}
EUVIMED